Mucosolvan La 75mg 10 Capsules

Description

MUCOSOLVAN once-daily prolonged-release capsules are a medicine intended to improve mucus clearance in respiratory illnesses with viscous mucus (expectorant). MUCOSOLVAN once-daily prolonged-release capsules are used as a treatment to improve mucus clearance in acute and chronic bronchial and lung disorders with viscous mucus. How to use The recommended dose is: Adults and adolescents aged 12 years and over: The usual dosage is one prolonged-release capsule (equivalent to 75 mg ambroxol hydrochloride/day) once daily. Method and duration of treatment MUCOSOLVAN once-daily prolonged-release capsules can be taken with or without food and should be swallowed whole with sufficient amounts of liquid (e.g., water, tea or fruit juice). You should consult a doctor if your symptoms worsen or if there is no improvement after 4-5 days. Please speak to your doctor or pharmacist if you feel that the effect of MUCOSOLVAN once-daily prolonged-release capsules is too strong or too weak. Warnings and precautions MUCOSOLVAN once-daily prolonged-release capsules should not be taken: If you are hypersensitive (allergic) to the active substance ambroxol hydrochloride or to any of the other ingredients of this medicine By children younger than 12 years. Warnings and Precautions Talk to your doctor or pharmacist before taking this medicine. There have been reports of severe skin reactions associated with the administration of ambroxol hydrochloride. If you develop a skin rash (including mucosal lesions in the mouth, throat, nose, eyes and genital region), stop taking MUCOSOLVAN once-daily prolonged-release capsules and seek medical advice immediately. Patients with impaired kidney or liver function If you suffer from impaired kidney function or a severe liver disease, MUCOSOLVAN once-daily prolonged-release capsules should only be used on medical advice. As with any medicine that is metabolised by the liver and then excreted via the kidneys, an accumulation of the metabolic products (metabolites) of ambroxol produced in the liver can be expected in patients with severe renal failure. In some rare bronchial disorders that are associated with excessive accumulation of secretions (e.g. malignant ciliary syndrome), MUCOSOLVAN once-daily prolonged-release capsules should only be used under medical supervision due to possible secretion congestion. Side Effects Like all medicines, MUCOSOLVAN once-daily prolonged-release capsules can cause side effects, although not everybody gets them. Storage Information Do not store above 30ºC. Drug Interactions Please tell your doctor or pharmacist if you are taking/using any other medicines, have recently taken/used any other medicines, or are intending to take/use other medicines. Ambroxol/Cough suppressants Simultaneous use of MUCOSOLVAN once-daily prolonged-release capsules and cough suppressants (antitussives) may lead to the development of dangerous secretion congestion in patients with respiratory illnesses that are associated with an increased formation of mucus, such as cystic fibrosis or bronchiectasis, due to the reduction of the cough reflex. Ingredients The active substance is: Ambroxol hydrochloride.